Cargando…
Economic evaluation of a leprosy innovation project in Northern Nigeria: cost-effectiveness analysis
BACKGROUND: The state of leprosy in Nigeria and the realities of post elimination era underscore the need for evidence- based cost-effective approach to early case detection for enhanced control and elimination of leprosy. This study evaluated the operational cost-effectiveness of a community delive...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618221/ https://www.ncbi.nlm.nih.gov/pubmed/36309705 http://dx.doi.org/10.1186/s12962-022-00393-w |
_version_ | 1784821002460463104 |
---|---|
author | Ezenduka, Charles C. Namadi, Abudulahi Tahir, Dahiru Nwosu, Uzoma Musa, Shuaibu N. |
author_facet | Ezenduka, Charles C. Namadi, Abudulahi Tahir, Dahiru Nwosu, Uzoma Musa, Shuaibu N. |
author_sort | Ezenduka, Charles C. |
collection | PubMed |
description | BACKGROUND: The state of leprosy in Nigeria and the realities of post elimination era underscore the need for evidence- based cost-effective approach to early case detection for enhanced control and elimination of leprosy. This study evaluated the operational cost-effectiveness of a community delivered Legacy Innovative Project implemented to enhance leprosy case detection in northern Nigeria. METHODS: Data were collected from an explorative cross-sectional study, undertaken in a practice setting among endemic communities in three states in northern Nigeria. Primary and secondary data were collected from the project, routine records and programme annual reports. Costs and effects were measured from both providers’ and patients’ perspectives, and outcome expressed as cost per new case detected. Incremental estimates of costs and effects of the project compared to routine practice were used to obtain the cost-effectiveness result, as incremental cost-effectiveness ratio (ICER). All costs were converted to the US Dollar at 2018exchange rate (N350 = US$1.00). Univariate sensitivity analysis was performed to evaluate uncertainties around the ICER. RESULTS: The Project overall detected a total of 347 newly confirmed leprosy cases at a total annual cost of US$49,337.19, averaging US$142.18 per new case detected. Key cost drivers included routine meetings, which accounted for 28% of total expenditure, while Social Mobilization and Training/Workshop accounted for17% respectively. Findings were similar across the states. Overall, the Project dominated routine practice with ICER of US$(-17.73) per additional/new case detected, as a very cost-effective strategy. Sensitivity analysis reinforced the cost-effectiveness result. CONCLUSIONS: The Legacy Innovative Project demonstrated a more efficient and cost-saving approach to leprosy case detection. Findings present important information to policy and programmes for enhanced control and elimination of leprosy in related settings. . |
format | Online Article Text |
id | pubmed-9618221 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-96182212022-10-31 Economic evaluation of a leprosy innovation project in Northern Nigeria: cost-effectiveness analysis Ezenduka, Charles C. Namadi, Abudulahi Tahir, Dahiru Nwosu, Uzoma Musa, Shuaibu N. Cost Eff Resour Alloc Research BACKGROUND: The state of leprosy in Nigeria and the realities of post elimination era underscore the need for evidence- based cost-effective approach to early case detection for enhanced control and elimination of leprosy. This study evaluated the operational cost-effectiveness of a community delivered Legacy Innovative Project implemented to enhance leprosy case detection in northern Nigeria. METHODS: Data were collected from an explorative cross-sectional study, undertaken in a practice setting among endemic communities in three states in northern Nigeria. Primary and secondary data were collected from the project, routine records and programme annual reports. Costs and effects were measured from both providers’ and patients’ perspectives, and outcome expressed as cost per new case detected. Incremental estimates of costs and effects of the project compared to routine practice were used to obtain the cost-effectiveness result, as incremental cost-effectiveness ratio (ICER). All costs were converted to the US Dollar at 2018exchange rate (N350 = US$1.00). Univariate sensitivity analysis was performed to evaluate uncertainties around the ICER. RESULTS: The Project overall detected a total of 347 newly confirmed leprosy cases at a total annual cost of US$49,337.19, averaging US$142.18 per new case detected. Key cost drivers included routine meetings, which accounted for 28% of total expenditure, while Social Mobilization and Training/Workshop accounted for17% respectively. Findings were similar across the states. Overall, the Project dominated routine practice with ICER of US$(-17.73) per additional/new case detected, as a very cost-effective strategy. Sensitivity analysis reinforced the cost-effectiveness result. CONCLUSIONS: The Legacy Innovative Project demonstrated a more efficient and cost-saving approach to leprosy case detection. Findings present important information to policy and programmes for enhanced control and elimination of leprosy in related settings. . BioMed Central 2022-10-29 /pmc/articles/PMC9618221/ /pubmed/36309705 http://dx.doi.org/10.1186/s12962-022-00393-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Ezenduka, Charles C. Namadi, Abudulahi Tahir, Dahiru Nwosu, Uzoma Musa, Shuaibu N. Economic evaluation of a leprosy innovation project in Northern Nigeria: cost-effectiveness analysis |
title | Economic evaluation of a leprosy innovation project in Northern Nigeria: cost-effectiveness analysis |
title_full | Economic evaluation of a leprosy innovation project in Northern Nigeria: cost-effectiveness analysis |
title_fullStr | Economic evaluation of a leprosy innovation project in Northern Nigeria: cost-effectiveness analysis |
title_full_unstemmed | Economic evaluation of a leprosy innovation project in Northern Nigeria: cost-effectiveness analysis |
title_short | Economic evaluation of a leprosy innovation project in Northern Nigeria: cost-effectiveness analysis |
title_sort | economic evaluation of a leprosy innovation project in northern nigeria: cost-effectiveness analysis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618221/ https://www.ncbi.nlm.nih.gov/pubmed/36309705 http://dx.doi.org/10.1186/s12962-022-00393-w |
work_keys_str_mv | AT ezendukacharlesc economicevaluationofaleprosyinnovationprojectinnorthernnigeriacosteffectivenessanalysis AT namadiabudulahi economicevaluationofaleprosyinnovationprojectinnorthernnigeriacosteffectivenessanalysis AT tahirdahiru economicevaluationofaleprosyinnovationprojectinnorthernnigeriacosteffectivenessanalysis AT nwosuuzoma economicevaluationofaleprosyinnovationprojectinnorthernnigeriacosteffectivenessanalysis AT musashuaibun economicevaluationofaleprosyinnovationprojectinnorthernnigeriacosteffectivenessanalysis |